Artículos de revistas
Clinical Study Of The Efficacy And Tolerability Of Lansoprazole In The Management Of Duodenal Ulcer [estudo Clinico Sobre A Eficacia E A Tolerabilidade De Lansoprazol No Tratamento Da Ulcera Duodenal]
Registro en:
Revista Brasileira De Medicina. , v. 55, n. 3, p. 156 - 160, 1998.
347264
2-s2.0-0031977326
Autor
Zaterka S.
De Magalhaes A.F.N.
Eisig J.N.
Costa Leite Carvalhaes A.A.
Chinzon D.
Navarro Rodriguez T.
Institución
Resumen
The present study aimed to evaluate the efficacy and tolerability of lansoprazole 30 mg once daily in healing duodenal ulcer in two Brazilian centers. Patients were evaluated on the basis of clinical and endoscopic criteria before treatment and two weeks after the beginning of treatment. The patients who were not healed (red or white scar: S1 or S2 according Sakitas's classification) were reevaluated 4 weeks after the beginning of treatment. Fifthy-eight patients completed the study. Endoscopic examination revealed that duodenal ulcer was healed (S1 or S2 according Sakitas's classification) 2 weeks after the beginning of treatment in 51 patients (87,9%). In the remaining seven patients (12,1%) the ulcer was healed at the end of treatment (4 weeks). Clinical symptoms (daytime epigastric pain, nocturnal epigastric pain, daytime heartburn, nocturnal heartburn, nausea, vomiting, post-prandial distention, anorexia, and dysphagia) were dramatically reduced two weeks after the beginning of treatment in terms of the number of patients presenting the symptom and the severity. The present study confirms the efficacy of lansoprazole in the treatment of duodenal ulcer. All patients who completed the study were healed. The adverse events reported were mild nature and were not considered related to the medication under study, not requiring discontinuation of treatment. With a marked efficacy lansoprazole is also safe. 55 3 156 160 Black, J.W., Duncan, W.A.M., Durant, C.J., Definition and antagonism of histamine H2-receptors (1972) Nature, 236, pp. 385-390 Brimblecombe, R.W., Duncan, W.A.M., Durant, C.J., Cimetidine - A non-thiourea H-receptors antagonist (1975) J Int Med Res, 3, pp. 86-92 Andersen, B.N., Medical treatment of peptic ulcer disease (1988) Acta Chir Scand Suppl, 547, pp. 88-92 Dammann, H.G., Dreyer, M., Kangah, R., First-choice treatment in uncomplicated ulcer disease: A case for acid inhibitors (1988) Scand J Gastroenterol, 23 (153 SUPPL.), pp. 62-70 Burland, W.L., Hawkins, B.W., Beresford, J., Cimetidine treatment for the prevention of duodenal ulcer: An international collaborative study (1980) Postgr Med J, 56, pp. 173-176 Lindberg, P., Brändström, A., Wallmark, B., Structure-activity relationships of omeprazole analogues and their mechanism of action (1987) Trends in Pharmacol Sci, 8, pp. 399-402 Lindberg, P., Brändström, A., Wallmark, B., Omeprazole: The first proton pump inhibitor (1990) Med Res Rev, 10 (1), pp. 1-54 Dahlgren, S., Domellöf, L., Hradsky, M., The effects of omeprazole and cimetidine on duodenal ulcer healing and the relief of symptoms (1988) Aliment Pharmacol Ther, 2 (6), pp. 483-492 Walan, A., Bader, J.P., Classen, M., Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer (1989) N Engl J Med, 320 (2), pp. 69-75 Maton, P.N., Omeprazole (1991) N Engl J Med, 324 (14), pp. 965-975 Lauritsen, K., Andersen, B.N., Laursen, L.S., Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial (1991) Gastroenterology, 100 (3), pp. 663-669 Bianchi Porro, G., Corinaldesi, R., Lazzaroni, M., Long term treatment with omeprazole 20mg three days a week or 10mg daily in the prevention of duodenal ulcer relapse (1994) Aliment Pharmacol Ther, 8 (5), pp. 541-548 Goh, K.L., Boonyapisit, S., Lai, K.H., Prevention of duodenal ulcer relapse with omeprazole 20mg daily, a randomized double-blind, placebo-controlled study (1995) J Gastroenterol Hepatol, 10 (1), pp. 92-97 Pilotto, A., Di Mario, F., Battaglia, G., The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly (1994) Clin Ther, 16 (6), pp. 935-941 Festen, H.P., Prevention of duodenal ulcer relapse by long-term treatment with omeprazole (1994) Scand J Gastroenterol, 29 (201 SUPPL.), pp. 39-41 Licht, H., Andrieu, J., Bognel, J.C., Lansoprazole versus ranitidine dans le traitement des ulcères duodenaux: Resultats d'un essai multicentrique controlé, randomisé en double insu sur groupes paralleles (1990) MCD, 19, pp. 251-255 Petite, J.P., Slama, J.L., Licht, H., Comparaison du lansoprazole (30mg) et de l'oméprazole (20mg) dans le traitement de l'ulcère duodenaux. Essai thérapeutique multicentrique comparatif en double aveugle (1993) Gastroenterol Clin Biol, 17 (5), pp. 334-340 Bader, J.P., Delchier, J.C., Clinical efficacy of pantoprazole compared with ranitidine (1994) Aliment Pharmacol Ther, 8 (1 SUPPL.), pp. 47-52 Judmater, G., Koeltz, H.R., Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer (1994) Aliment Pharmacol Ther, 8 (1), pp. 81-86. , Pantoprazole-Duodenal Ulcer-Study Group Zaterka, S., Massuda, H., Chinzon, D., Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: A multicenter double-blind, parallel group study (1993) Am J Gastroenterol, 88 (3), pp. 397-401 Meneghelli, U.G., Zaterka, S., Castro, L.P., (1998) Pantoprazole Versus Ranitidine in the Treatment of Duodenal Ulcer. A Multicenter Study in Brazil, , Enviado para publica̧ão Marks, I.N., Winter, T.A., Lucke, W., Omeprazole and ranitidine in duodenal ulcer healing (1988) S Afr Med J, 74 (SUPPL.), pp. 54-56